News & Insights | Clinical & Medical Affairs

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

hVIVO acquires Germany’s CRS for ‘significant European foothold’

EU Clinical Trials Regulation will make drug studies more transparent

Link Medical buys CRST to build Northern European CRO

Study raises transparency concerns about clinical trials involving AI

New industry group to promote multisite networks to sponsors, CROs

Lindus Health raises $55m to advance AI tech, expand team

JPM 2025: ICON, PPD talk trial sector volatility; NVIDA outlines IQVIA accord

Fine-tuned AI could aid trial design and transparency compliance, study says

$165m PE investment sets Caidya on M&A trail

Sponsor trial spending surge will coincide with supplier streamlining

Proposed UK trial rules would increase clinical trial transparency

FDA: Tissue biopsies used in trials must be justified

Veeda rebrands with eye on innovator drug trials

EMA changes transparency rules to emphasize patient and trial staff privacy

Upcoming ICH GCP guide will increase use of risk-based monitoring, says ACRO

Streamlining first-in-human trials with IRT systems

Lessons learned from implementing eConsent to IRT integration

Patient centricity, market access, and private equity fueled CRO M&A in 2024

Private equity firm sets out expansion plan for EMAS Pharma

Carta Healthcare buys trial data abstraction counterpart Realyze Intelligence

Quick Links